# Sally Arai, M.D. – FDA Inspection, Mar 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/sally-arai-md/6bd50f3c-f479-4ed7-9b74-5e0c0ce40343
Source feed: FDA_Inspections

> FDA inspection 1232013 of Sally Arai, M.D., March 06, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 50.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232013
- Company Name: Sally Arai, M.D.
- Inspection Date: 2024-03-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)
- [Company Rep](https://www.keypedia.com/people/stephanie-barragan/fc1bc901-1467-4fdd-bee3-f87f2db3a1fa)

Company: https://www.keypedia.com/companies/sally-arai-md/72331a19-1dae-4f7e-85cf-d607418e9736

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c